Grant: Discovery Grants Program - Individual
Simon Fraser University
$30,000.00
Regulation of the dopamine transporter by microtubule proteins
FY 2012-13
Summary
Dopamine (DA) is a neurotransmitter that is involved in various neurological systems that affect movement, reward, learning and memory. Release of DA from the presynaptic neuron can bind to postsynaptic receptors to facilitate neurotransmission. To ""turn off"" the DA signal requires clearance of DA from the synapse, which is largely mediated by dopamine transporter (DAT), thus implicating the importance of understanding how the DAT works. Improper DAT function can lead to states of hyper- or hypo-dopaminergic activity, which has been associated with various brain disorders (e.g., schizophrenia, drug addiction, Parkinson's disease). DAT-mediated re-uptake of synaptically released DA is largely dependent on DAT cell surface localization. This proposal will examine the relationship between dynamic neuronal structural proteins and the DAT. Protein-protein interactions between DAT and cytoskeletal proteins may facilitate DAT localization to specific subcellular areas or cell surface domains. We will specifically focus on the interaction between DAT and tubulin, which are proteins involved in forming microtubules within cells. In addition to a previous report showing an association between DAT and tubulin, we have preliminary evidence to suggest a direct interaction between the DAT and tubulin. Therefore, to investigate the interaction between DAT and tubulin this proposal will pursue the following objectives: (1) characterize the interaction between DAT and tubulin; (2) identify the functional effects of the DAT-tubulin interaction; (3) examine the behavioural effects of disrupting the DAT-tubulin interaction. This proposal will comprehensively define and identify the physiological significance of the interaction between DAT and microtubule proteins. These studies may reveal a general mechanism for the regulation of biogenic amine transporters by cytoskeletal proteins. In addition, understanding how the DAT is regulated by tubulin may provide insight into the molecular mechanism of dopaminergic hyperactivity/hypoactivity implicated in various brain disorders.
Program
Discovery Grants Program - Individual
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
371631-2009
Name nom
Lee, Frank
Department département
Health Sciences, Faculty of
Organization id
5
Institution établissement
Simon Fraser University
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2009
Award amount
30000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
32
Committee name en
Cell Biology
Committee name fr
Biologie cellulaire
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
6400
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Life sciences research related to human health and disease
Research subject fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Partie
4
Nb partie
5
Application title
Regulation of the dopamine transporter by microtubule proteins
Keyword
NSERC
Application summary
Dopamine (DA) is a neurotransmitter that is involved in various neurological systems that affect movement, reward, learning and memory. Release of DA from the presynaptic neuron can bind to postsynaptic receptors to facilitate neurotransmission. To ""turn off"" the DA signal requires clearance of DA from the synapse, which is largely mediated by dopamine transporter (DAT), thus implicating the importance of understanding how the DAT works. Improper DAT function can lead to states of hyper- or hypo-dopaminergic activity, which has been associated with various brain disorders (e.g., schizophrenia, drug addiction, Parkinson's disease). DAT-mediated re-uptake of synaptically released DA is largely dependent on DAT cell surface localization. This proposal will examine the relationship between dynamic neuronal structural proteins and the DAT. Protein-protein interactions between DAT and cytoskeletal proteins may facilitate DAT localization to specific subcellular areas or cell surface domains. We will specifically focus on the interaction between DAT and tubulin, which are proteins involved in forming microtubules within cells. In addition to a previous report showing an association between DAT and tubulin, we have preliminary evidence to suggest a direct interaction between the DAT and tubulin. Therefore, to investigate the interaction between DAT and tubulin this proposal will pursue the following objectives: (1) characterize the interaction between DAT and tubulin; (2) identify the functional effects of the DAT-tubulin interaction; (3) examine the behavioural effects of disrupting the DAT-tubulin interaction. This proposal will comprehensively define and identify the physiological significance of the interaction between DAT and microtubule proteins. These studies may reveal a general mechanism for the regulation of biogenic amine transporters by cytoskeletal proteins. In addition, understanding how the DAT is regulated by tubulin may provide insight into the molecular mechanism of dopaminergic hyperactivity/hypoactivity implicated in various brain disorders.